)
Edge29 May 2026
Who You Gonna Call? The Story of Rollins
How Rollins built one of America's most consistent businesses through recurring pest control, trusted local brands, and decades of acquisitions.
Fredun Pharmaceuticals
Fredun Pharmaceuticals (539730) investor relations material
Fredun Pharmaceuticals Q4 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 25/26 earnings summary25 May, 2026
Executive summary
Audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, were approved, showing continued growth in revenue and profitability year-over-year.
Board recommended a final dividend of 7% (₹0.70 per share) for FY 2025-26, subject to shareholder approval.
Issuance of bonus shares in a 2:1 ratio approved, with bonus shares to be issued from reserves and/or share premium.
Increase in authorized share capital from ₹10 crore to ₹50 crore, pending shareholder approval.
Appointments of new internal and cost auditors for FY 2026-27 confirmed.
Financial highlights
Standalone revenue for FY 2025-26 was ₹63,912.17 lakh, up from ₹45,626.82 lakh in FY 2024-25.
Standalone net profit for FY 2025-26 was ₹3,337.24 lakh, compared to ₹2,046.41 lakh in FY 2024-25.
Consolidated revenue for FY 2025-26 reached ₹63,912.49 lakh, up from ₹45,626.85 lakh year-over-year.
Consolidated net profit for FY 2025-26 was ₹3,279.00 lakh, up from ₹1,939.58 lakh in FY 2024-25.
Basic EPS (standalone) for FY 2025-26 was ₹20.22, up from ₹14.98 in FY 2024-25; consolidated EPS was ₹19.70, up from ₹12.71.
Outlook and guidance
Board expects continued growth, supported by capital expansion and bonus issue, with dividend payout reflecting confidence in future performance.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Fredun Pharmaceuticals
- Strong revenue, margin, and profit growth with improved EPS and stable capital structure.539730
Q3 25/2617 Feb 2026 - Revenue and profit increased, and a new retail subsidiary was established.539730Q3 24/258 Jan 2026
- Q1 FY25 saw strong revenue and profit growth, with EPS rising to ₹8.79.539730Q1 24/2525 Nov 2025
- Revenue and profit soared year-on-year, with robust new age business and board expansion.539730Q1 25/2616 Nov 2025
- Double-digit revenue and profit growth, improved margins, and positive cash flow in H1 FY26.539730Q2 25/2611 Nov 2025
- Q2 FY25 saw revenue and profit growth, but cash flow and liquidity pressures increased.539730Q2 24/2513 Jun 2025
- FY25 saw robust growth, a 7% dividend, and first-time consolidation of new subsidiaries.539730Q4 24/256 Jun 2025
Next Fredun Pharmaceuticals earnings date
Q1 26/2731 Jul, 2026
Fredun Pharmaceuticals
Next Fredun Pharmaceuticals earnings date
Q1 26/2731 Jul, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage